Evidence map›Paper›PMID 25646303›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

CD40 is required for protective immunity against liver stage Plasmodium infection.

Sara A Murray, Isaac Mohar, Jessica L Miller, Katherine J Brempelis, Ashley M Vaughan, Stefan H I Kappe, Ian N Crispe

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. CD4Malaria journal · 2022
    Article
  3. Article
  4. Accelerator or Brake: Immune Regulators in Malaria.Frontiers in cellular and infection microbiology · 2020
    Review
  5. Article
  6. Article
  7. Infectious Sporozoites ofFrontiers in immunology · 2018
    Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sara A MurrayDepartment of Global Health, University of Washington, Seattle, WA 98195;
Isaac MoharDepartment of Pathology, University of Washington, Seattle, WA 98195; and.
Jessica L MillerSeattle Biomedical Research Institute, Seattle, WA 98109.
Katherine J BrempelisDepartment of Global Health, University of Washington, Seattle, WA 98195;
Ashley M VaughanSeattle Biomedical Research Institute, Seattle, WA 98109.
Stefan H I KappeDepartment of Global Health, University of Washington, Seattle, WA 98195; Seattle Biomedical Research Institute, Seattle, WA 98109.
Ian N CrispeDepartment of Pathology, University of Washington, Seattle, WA 98195; and crispen@u.washington.edu.
University of Washington · USCenter for Infectious Disease Research · US

Funding

Diseases of Public Health Importance Training GrantT32AI007509 · NIAID · UNIVERSITY OF WASHINGTON · PI LUND, JENNIFER M · 1997 to 2024
$6.3M
NIAID NIH HHS T32 AI007509NIAID NIH HHS T32AI007509-13
6 · The paper itself

Abstract

The costimulatory molecule CD40 enhances immunity through several distinct roles in T cell activation and T cell interaction with other immune cells. In a mouse model of immunity to liver stage Plasmodium infection, CD40 was critical for the full maturation of liver dendritic cells, accumulation of CD8(+) T cells in the liver, and protective immunity induced by immunization with the Plasmodium yoelii fabb/f(-) genetically attenuated parasite. Using mixed adoptive transfers of polyclonal wild-type and CD40-deficient CD8(+) T cells into wild-type and CD40-deficient hosts, we evaluated the contributions to CD8(+) T cell immunity of CD40 expressed on host tissues including APC, compared with CD40 expressed on the CD8(+) T cells themselves. Most of the effects of CD40 could be accounted for by expression in the T cells' environment, including the accumulation of large numbers of CD8(+) T cells in the livers of immunized mice. Thus, protective immunity generated during immunization with fabb/f(-) was largely dependent on effective APC licensing via CD40 signaling.

Indexed as

Adoptive TransferAnimalsCD40 AntigensCD8-Positive T-LymphocytesDendritic CellsFemaleGene DeletionGene ExpressionHepatocytesImmunity, InnateLiverLymphocyte ActivationMalariaMalaria VaccinesMiceMice, Inbred C57BLCD40 AntigensMalaria VaccinesProtozoan ProteinsVaccines, Attenuated

Identifiers

PMID25646303
PMCPMC4340756
OpenAlexW1569380315

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.